Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 140 (7), 1990-1999
- https://doi.org/10.1053/j.gastro.2011.03.010
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis CGastroenterology, 2011
- Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis CGastroenterology, 2010
- Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus–Induced Cirrhosis. A 12-Year Prospective Follow-Up StudyHepatology, 2010
- Meta‐analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis CInternational Journal of Cancer, 2009
- Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cellsHepatology International, 2009
- The global burden of hepatitis CLiver International, 2009
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005
- Treatment of Hepatitis C Virus-Related Cirrhosis: A Randomized, Controlled Trial of Interferon Alfa–2B Versus No TreatmentHepatology, 1999